CK2 inhibitor 2

Description: CK2 Inhibitor 2, characterized as a potent, selective, and orally active inhibitor of CK2, demonstrates an impressive IC50 value of 0.66 nM. It exhibits high selectivity towards Clk2 with an IC50 of 32.69 nM in comparison to CK2. Furthermore, CK2 Inhibitor 2 has been shown to possess promising antiproliferative and antitumor activities [1]. Target: Casein Kinase. Smiles: N(C1=C2C(=C3C(=N1)C=C(C(NCCO)=O)C=C3)C=NC=C2)C4=CC(Cl)=CC=C4. References: Wang Y, et, al. Discovery of 5-(3-Chlorophenylamino)benzo[ c][2,6]naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition. J Med Chem. 2021 Apr 22,64(8):5082-5098.